NCT07652359 Empowering Monterey Bay Residents for Activated, Collaborative, and Equitable Care
| NCT ID | NCT07652359 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Shared Decision-Making |
| Study Type | INTERVENTIONAL |
| Enrollment | 138 participants |
| Start Date | 2026-07-14 |
| Primary Completion | 2029-07-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 138 participants in total. It began in 2026-07-14 with a primary completion date of 2029-07-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the EMBRACE Study is to evaluate whether a facilitated intervention improves shared decision-making (SDM) and patient activation among low-income and minority individuals more than usual care only. The ultimate goal is to enhance SDM and patient activation in care.
Eligibility Criteria
Inclusion Criteria: * Participants must be receiving clinical care by a primary care physician in the Monterey area * Participants must be 18 years or older. * Participants must speak either English or Spanish. * Participants must be able to consent verbally in English or Spanish to all study procedures. * Participants must self-identify as a racial/ethnic minorities OR identify as having low-income status Exclusion Criteria: \- Patients unable to respond to survey questions in either English or Spanish.
Contact & Investigator
Manali I Patel, MD, MPH, MS
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT07652359 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Shared Decision-Making. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07652359 currently recruiting?
Yes, NCT07652359 is actively recruiting participants. Contact the research team at manalip@stanford.edu for enrollment information.
Where is the NCT07652359 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT07652359 clinical trial?
NCT07652359 is sponsored by Stanford University. The principal investigator is Manali I Patel, MD, MPH, MS at Stanford University. The trial plans to enroll 138 participants.